← Leaderboards
W. Oliver Tobin
Mayo Clinic Rochester
$1,548,354
Attributed
$3,096,707
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $623.1K · FY2020–24$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,096,707 · 1
By mechanism
R01$3,096,707 · 1
Top collaborators
- Jeanette E Eckel Passow5 shared
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Nadia N Laack$4,554,228
- Charles Lee Howe$6,719,913
- Scott H Kaufmann$29,002,745
- Jeanette E Eckel Passow$2,181,111
- Evanthia Galanis$13,573,895
Others in their field
Other Emerging Leaders on “Glioma”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Rachana Agarwal · Leidos Biomedical Research, Inc.$15,241,462
- Mario Luca Suva · Brigham And Women'S Hospital$9,318,589
- Howard A. Fine · Weill Medical Coll Of Cornell Univ$6,388,702
- David M. Ashley · Duke University$5,976,526
- Pavithra Viswanath · University Of California, San Francisco$5,081,972
Research focus
GliomaIatrogenesisAccurate DiagnosisAcademic Medical CentersGenotypeAdultBrain NeoplasmsBrain PathologyBiopsyCentral Nervous System LymphomaBrainCharacteristicsClinically SignificantCohortCostDemyelinating DiseasesDiagnosisDiagnosticDiagnostic AccuracyDifferential DiagnosisDiffuseEffectivenessExcisionImage
Grant awards (5)
Diagnosis of indeterminate brain lesions using MRI-based machine learning and polygenic risk models$604,387
R01 · FY2024 · NS
Diagnosis of indeterminate brain lesions using MRI-based machine learning and polygenic risk models$623,080
R01 · FY2023 · NS
Diagnosis of indeterminate brain lesions using MRI-based machine learning and polygenic risk models$623,080
R01 · FY2022 · NS
Diagnosis of indeterminate brain lesions using MRI-based machine learning and polygenic risk models$623,080
R01 · FY2021 · NS
Diagnosis of indeterminate brain lesions using MRI-based machine learning and polygenic risk models$623,080
R01 · FY2020 · NS